CAE Healthcare delivers simulation training solutions to hospitals, physicians, nurses, students, emergency responders and the military in 80 countries around the world. With a mission to improve patient safety and outcomes, CAE Healthcare develops each product in partnership with clinicians and clinical educators whose aim is to ensure physiological accuracy and educational relevance. Today, CAE Healthcare offers turnkey solutions and services as well as the broadest spectrum of medical simulation products on the market.
Baudax Bio is a commercial stage pharmaceutical company focused on developing and commercializing innovative products for patients in acute care settings. We are committed to bringing clinically meaningful therapeutic options to patients, health care providers, and payers. We have developed a non-opioid analgesic and are developing neuromuscular blocking and reversal agents, for use in anesthesia. We believe we can create value for healthcare providers, patients, and shareholders.
At Edwards Lifesciences, we strive to provide the valuable information you need to hemodynamically optimize your moderate to high-risk surgery patients. From the very first Swan-Ganz catheter to the latest ClearSight noninvasive cuff, FloTrac sensor, and EV1000 Clinical Platform, our goal remains the same: to give you the clarity you need to maintain your moderate and high-risk surgery patients in the optimal volume range. Visit Edwards.com/ESR for valuable resources for you and your surgical team.
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies that are used to help care for critically and chronically ill patients. Fresenius Kabi offers one of the largest U.S. injectable medicine portfolios for anesthesia providers, including Diprivan® (propofol) and Naropin® (ropivacaine). We also have a growing number of ready-to-administer products designed to help streamline medication administration.
Heron’s mission is to improve patient’s lives by developing best-in-class medicines that address major unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to proven pharmacological agents. Our portfolio includes SUSTOL® (granisetron) and CINVANTITM (aprepitant), as well as one product in development; HTX-011, a novel fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam being investigated for application into the surgical site to reduce postoperative pain and the need for opioid analgesics for 72 hours.
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. In 1995, Masimo debuted SET® Measure-through Motion and Low Perfusion™ pulse oximetry, estimated to be used on more than 100 million patients annually. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry, allowing noninvasive and continuous monitoring of additional physiologic parameters that previously could only be measured invasively, such as total hemoglobin (SpHb®). We continue to advance noninvasive monitoring, connectivity, and automation with innovations like the Root® patient monitoring and connectivity hub and the Patient SafetyNet™ supplemental remote monitoring solution.
Medtronic plc (www.medtronic.com), is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
To learn more about ASA’s Industry and Corporate Support programs, please visit the Partner With Purpose website.